InsidersTradesSigma
Track the ST葫芦娃 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST葫芦娃 has logged 4 insider filings. Market capitalisation: €2.3bn. The latest transaction was filed on 28 November 2022 (Sale). Among the most active insiders: 吴雪雯. The full history is accessible without an account.
4
Insider Decl.
n/a
Thresholds
€13,854
3 ops.
Buy Volume
€5,735
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,140 of 29,065 companies
25.4
score / 100
Value33
Quality18
FCF yld2.3%
Earn yld-12%
EV/EBITDA·
ROE-56%
Gross mgn29%
Net mgn-32%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 November 2022
关于 ST葫芦娃
ST葫芦娃 是一家在 XSHG 市场上市的公司，专注于健康和制药领域。它致力于开发和商业化创新的患者福祉解决方案。